Corsaire metabolomics platform, Biogenouest (France)
I have recently finished my PhD at Imperial College London (UK) within the Stratified Medicine Graduate Training Programme. My PhD research aimed at exploring the bidirectional interaction between drugs and the host microbiome, a key aspect to consider in pharmacological and toxicological studies. To do so, I have used 1H NMR spectroscopy, untargeted and targeted UPLC-MS based metabolic profiling.
My Master training was specialized in the study of chemical transformations in biological systems, natural products and OMICs sciences, which gave me the opportunity to investigate the toxicity of Bisphenol A on human testicular explants by MALDI-IMS at the Protim platform in 2014 (Rennes, France) and on the development of a novel class of irreversible kinase inhibitors at the Auckland Cancer Society Research Centre (New Zealand).
Since the beginning of 2020, I have started a new position as a facilitator of the structural and metabolomics analysis network of Biogenouest (France). My responsibilities are to coordinate the research teams within the network, improve their visibility and support their management and the continuous improvement of their quality system. I am also part of the early career scientific committee of MSACL, within the Tox, TDM and endocrine group.